Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance
書誌事項
- 公開日
- 2017-10
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- DOI
-
- 10.1016/j.jinorgbio.2017.07.002
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Journal of Inorganic Biochemistry
-
Journal of Inorganic Biochemistry 175 47-57, 2017-10
Elsevier BV
